Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Chinese researchers have discovered that the spleen could be instrumental in treating diabetes, following successful cell transplant experiments.

Eli Lilly's Mounjaro has seen a positive reception in India, capturing significant sales and market interest since its launch ...

India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's ...

Diabetes continues to emerge as a critical public health challenge globally and in Thailand, with alarming increases among ...

Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of developing type 1 diabetes (T1D) and predict treatment responses, potentially ...

China has an estimated 233 million diabetic patients by the year 2023, up 163 percent over 2005, latest study by Chinese ...

Researchers say nanoparticles could help engineer the spleen – a more promising long-term survival site than the liver – into ...